HTB Stock Analysis: HomeTrust Bancshares | NYSE

Banks - Regional | NYSE, USA | Market Cap: 734m USD | 12M Return: 16.3% | US4378721041 | Charts, Fundamentals & Technical Analysis

Deposit Accounts, Real Estate Loans, Commercial Lending, Healthcare Banking
Total Rating 54
Safety 30
Buy Signal -0.43
Regional Banks
Sub-Industry Rotation: +2.9
Market Cap: 734M
Avg Turnover: 4.82M
Risk 3d forecast
Volatility25.6%
VaR 5th Pctl4.20%
VaR vs Median-0.65%
Reward TTM
Sharpe Ratio0.63
Rel. Str. IBD62
Rel. Str. Peer Group36.9 pctl
Character TTM
Beta0.352
Beta Downside0.333
Hurst Exponent0.485
Choppyness73.7%
Drawdowns 3y
Max DD17.73%
CAGR/Max DD1.60
CAGR/Mean DD5.13
EPS (Earnings per Share) EPS (Earnings per Share) of HTB over the last years for every Quarter: "2021-09": 0.65, "2021-12": 0.68, "2022-03": 0.51, "2022-06": 0.39, "2022-09": 0.6, "2022-12": null, "2023-03": 0.4149, "2023-06": 0.8875, "2023-09": 0.88, "2023-12": 0.79, "2024-03": 0.88, "2024-06": 0.73, "2024-09": 0.76, "2024-12": 0.97, "2025-03": 0.84, "2025-06": 1, "2025-09": 0.95, "2025-12": 0.93, "2026-03": 0.99, "2026-06": 0.94, "2026-09": 1.11,
EPS CAGR: 9.54%
EPS Trend: 91.0%
Last SUE: 2.68
Qual. Beats: 1
Revenue Revenue of HTB over the last years for every Quarter: 2021-09: 39.657, 2021-12: 38.668, 2022-03: 37.142, 2022-06: 39.842, 2022-09: 43.337, 2022-12: 48.729, 2023-03: 58.076, 2023-06: 65.937, 2023-09: 70.492, 2023-12: 71.315, 2024-03: 72.175, 2024-06: 73.527, 2024-09: 74.931, 2024-12: 74.441, 2025-03: 71.662, 2025-06: 72.322, 2025-09: 74.146, 2025-12: 72.863, 2026-03: 71.528, 2026-06: 69.341, 2026-09: 70.149998,
Rev. CAGR: 1.42%
Rev. Trend: 43.3%
Last SUE: 4.00
Qual. Beats: 1

Warnings

Choppy
Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.4% 0
Feb -1.7% 4
Mar -1.1% 28
Apr -1.0% 14
May +1.1% 14
Jun +2.5% 4
Jul +0.6% 14
Aug -1.3% 14
Sep -2.2% 14
Oct +0.3% 4
Nov +2.6% 21
Dec +1.7% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: HTB HomeTrust Bancshares

HomeTrust Bancshares, Inc. (NYSE: HTB) is the holding company for HomeTrust Bank, a U.S. community bank founded in 1926 and headquartered in Asheville, North Carolina. It provides standard retail and commercial banking products-including checking, savings, money market, and certificate of deposit accounts-alongside a diversified loan portfolio covering residential real estate, multifamily, home equity, construction, indirect auto finance, commercial real estate, and commercial and industrial lending. The company also offers small business administration loans, equipment finance and municipal leases, cash management, and online/mobile banking services.

On the investment side, HomeTrust maintains a securities portfolio of U.S. government agency and government-sponsored enterprise debt, municipal and corporate bonds, commercial paper, and FDIC-insured certificates of deposit-a typical liquidity and yield-management approach for U.S. community banks.

A distinguishing element of HomeTrusts business model is its dedicated healthcare banking vertical, which delivers relationship-based financial services to medical, dental, and veterinary practices across the business lifecycle, from acquisition and ownership transitions through expansion. This specialized niche complements its general community bank franchise and is a notable differentiator within the regional banking sub-industry.

Headlines to Watch Out For
  • Net interest margin compresses as Fed cuts rates pressure spreads
  • Healthcare banking niche drives fee income and deposit growth
  • Southeast commercial loan expansion lifts revenue mix
  • Real estate loan credit costs rise on housing market softening
Piotroski VR-10 (Strict) 5.0
Net Income: 66.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.55 > 1.0
NWC/Revenue: -1.08k% < 20% (prev -1.23k%; Δ 145.7% < -1%)
CFO/TA 0.03 > 3% & CFO 120.5m > Net Income 66.5m
Net Debt (-179.8m) to EBITDA (92.9m): -1.94 < 3
Current Ratio: 0.14 > 1.5 & < 3
Outstanding Shares: last quarter (16.0m) vs 12m ago -6.60% < -2%
Gross Margin: 74.31% > 18% (prev 70.22%; Δ 4.10% > 0.5%)
Asset Turnover: 6.30% > 50% (prev 6.37%; Δ -0.07% > 0%)
Interest Coverage Ratio: 1.18 > 6 (EBIT TTM 81.1m / Interest Expense TTM 68.8m)
Altman Z'' -3.93
A: -0.70 (Total Current Assets 508.7m - Total Current Liabilities 3.58b) / Total Assets 4.42b
B: 0.11 (Retained Earnings 479.8m / Total Assets 4.42b)
C: 0.02 (EBIT TTM 81.1m / Avg Total Assets 4.51b)
D: 0.15 (Book Value of Equity 570.1m / Total Liabilities 3.85b)
Altman-Z'' = -3.93 = D
Beneish M -3.28
DSRI: 0.81 (Receivables 13.4m/17.1m, Revenue 283.9m/292.6m)
GMI: 0.94 (GM 70.22% / 74.31%)
AQI: 0.95 (AQ_t 0.87 / AQ_t-1 0.91)
SGI: 0.97 (Revenue 283.9m / 292.6m)
TATA: -0.01 (NI 66.5m - CFO 120.5m) / TA 4.42b)
Beneish M = -3.28 (Cap -4..+1) = AA
What is the price of HTB shares?

As of November 20, 2026, the stock is trading at USD 45.50 with a total of 91,243 shares traded. Over the past week, the price has changed by -3.64%, over one month by -2.09%, over three months by -3.09% and over the past year by +16.31%.

Current recommended Stop Loss: 44.20 (which is 2.9% or 1.3 ATR below the current price).

Is HTB a buy, sell or hold?

HomeTrust Bancshares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HTB.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the HTB price?
Analysts Target Price 55.3 21.4%
HomeTrust Bancshares (HTB) - Fundamental Data Overview as of 20 November 2026
Market Cap USD = 733.6m (733.6m USD * 1.0 USD.USD)
P/E Trailing = 11.6826
P/E Forward = 11.3379
P/S = 3.4493
P/B = 1.2878
Revenue TTM = 283.9m USD
EBIT TTM = 81.1m USD
EBITDA TTM = 92.9m USD
Long Term Debt = 10.2m USD (from longTermDebt, last fiscal year)
Short Term Debt = 50.0m USD (from shortLongTermDebt, last quarter)
Debt = 214.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -179.8m USD (calculated: Debt 214.0m - CCE 393.8m)
Enterprise Value = 553.7m USD (733.6m + Debt 214.0m - CCE 393.8m)
Interest Coverage Ratio = 1.18 (Ebit TTM 81.1m / Interest Expense TTM 68.8m)
EV/FCF = 4.79x (Enterprise Value 553.7m / FCF TTM 115.5m)
FCF Yield = 20.86% (FCF TTM 115.5m / Enterprise Value 553.7m)
FCF Margin = 40.69% (FCF TTM 115.5m / Revenue TTM 283.9m)
Net Margin = 23.42% (Net Income TTM 66.5m / Revenue TTM 283.9m)
Gross Margin = 74.31% ((Revenue TTM 283.9m - Cost of Revenue TTM 72.9m) / Revenue TTM)
Gross Margin QoQ = 75.44% (prev 75.77%)
Tobins Q-Ratio = 0.13 (Enterprise Value 553.7m / Total Assets 4.42b)
Interest Expense / Debt = 32.13% (Interest Expense 68.8m / Debt 214.0m)
Taxrate = 17.97% (14.6m / 81.1m)
NOPAT = 66.5m (EBIT 81.1m * (1 - 17.97%))
Current Ratio = 0.14 (Total Current Assets 508.7m / Total Current Liabilities 3.58b)
Debt / Equity = 0.38 (Debt 214.0m / totalStockholderEquity, last quarter 570.1m)
Debt / EBITDA = -1.94 (Net Debt -179.8m / EBITDA 92.9m)
Debt / FCF = -1.56 (Net Debt -179.8m / FCF TTM 115.5m)
Total Stockholder Equity = 591.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.48% (Net Income 66.5m / Total Assets 4.42b)
RoE = 11.25% (Net Income TTM 66.5m / Total Stockholder Equity 591.0m)
RoCE = 13.48% (EBIT 81.1m / Capital Employed (Equity 591.0m + L.T.Debt 10.2m))
RoIC = 8.07% (NOPAT 66.5m / Invested Capital 824.0m)
WACC = 11.24% (E(733.6m)/V(947.6m) * Re(6.83%) + D(214.0m)/V(947.6m) * Rd(32.13%) * (1-Tc(0.18)))
Discount Rate = 6.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -66.85 | Cagr: -2.42%
[DCF] Terminal Value 69.21% ; FCFF base≈88.8m ; Y1≈101.8m ; Y5≈149.8m
[DCF] Fair Price = 105.6 (EV 1.49b - Net Debt -179.8m = Equity 1.67b / Shares 15.8m; r=11.24% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.96 | EPS CAGR: 9.54% | SUE: 2.68 | # QB: 1
Revenue Correlation: 43.33 | Revenue CAGR: 1.42% | SUE: 4.0 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.98 | Chg30d=+0.82% | Revisions=+0% | Analysts=5
EPS current Year (2026-12-31): EPS=4.01 | Chg30d=+7.38% | Revisions=+57% | GrowthEPS=+7.9% | GrowthRev=+3.1%
EPS next Year (2027-12-31): EPS=4.40 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+9.6% | GrowthRev=+52.1%
[Analyst] Revisions Ratio: +21% (up=7, down=4)